Skip to main content
main-content

07.03.2017

memo inOncology Special Issue Preceptorship report

memo SPECIAL ISSUES offer informative, educational reports from leading international congresses. Sponsored by Boehringer Ingelheim and produced by Springer, this educational resource is available for free.

memo - Magazine of European Medical Oncology OnlineFirst articles

23.02.2018 | short review

Targeting angiogenesis in lung cancer

Angiogenesis inhibition is a promising way to inhibit and eradicate cancer. Many attempts have been made to use this tool for the treatment of lung cancer. Some success has been reported, and antiangiogenic drugs are actively being investigated in …

23.02.2018 | short review

Antiangiogenic therapies in ovarian cancer

Antiangiogenic compounds were the first active targeted agents implemented in the treatment of ovarian cancer. Bevacizumab and tyrosine kinase inhibitors such as pazopanib, nintedanib and cediranib target the VEGF pathway, while trebananib was …

23.02.2018 | editorial

Uro-oncology 2018: new horizons, new treatment options, improved patient outcomes

21.02.2018 | short review Open Access

Short overview on the current standard of treatment in newly diagnosed multiple myeloma

The treatment of newly diagnosed multiple myeloma has changed dramatically over the past 20 years, from near uniform application of chemotherapy to a patient performance status- and risk-based approach. Furthermore, initiation of treatment …

21.02.2018 | short review

Practice-changing developments in early use of chemohormonal therapy in metastatic prostate cancer

The STAMPEDE and CHAARTED trials brought about practice-changing innovation in the management of patients with metastatic, castration-naive prostate cancer (CNPC). These trials reported a clinically meaningful overall survival benefit of …

Aktuelle Ausgaben

Über diese Zeitschrift

The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments.

As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

Official Journal of the Central European Cooperative Oncology Group (CECOG) and the Austrian Society of Haematology and Oncology (OeGHO).

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise